trending Market Intelligence /marketintelligence/en/news-insights/trending/ejnPrVliR7ZPqKYzuiOJ9w2 content esgSubNav
In This List

US FDA clears Roche's Elecsys blood test for potential heart attack

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


US FDA clears Roche's Elecsys blood test for potential heart attack

The U.S. FDA approved Roche Holding Ltd.'s Elecsys troponin T blood test to diagnose patients with a suspected heart attack.

This makes Roche the first in-vitro diagnostics company in the U.S. to provide the next generation blood test.